Vanguard Group Inc. Has $255.33 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

Vanguard Group Inc. increased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 18,997,973 shares of the company’s stock after acquiring an additional 586,626 shares during the quarter. Vanguard Group Inc. owned about 7.68% of Oscar Health worth $255,333,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC raised its position in shares of Oscar Health by 29.5% in the third quarter. FMR LLC now owns 109,002 shares of the company’s stock valued at $2,312,000 after buying an additional 24,801 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Oscar Health by 9.2% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company’s stock worth $561,000 after acquiring an additional 2,236 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Oscar Health by 29.2% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 353,491 shares of the company’s stock valued at $7,498,000 after acquiring an additional 79,801 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Oscar Health by 27.1% during the 3rd quarter. Janus Henderson Group PLC now owns 72,236 shares of the company’s stock valued at $1,532,000 after acquiring an additional 15,400 shares during the period. Finally, Point72 Asset Management L.P. increased its position in shares of Oscar Health by 30.3% in the third quarter. Point72 Asset Management L.P. now owns 1,212,096 shares of the company’s stock worth $25,709,000 after purchasing an additional 281,858 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on OSCR. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Oscar Health has an average rating of “Hold” and an average target price of $20.21.

Oscar Health Price Performance

Shares of OSCR opened at $12.99 on Friday. The firm has a market cap of $3.25 billion, a PE ratio of -649.18 and a beta of 1.75. Oscar Health, Inc. has a 52-week low of $12.25 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The business’s 50 day moving average price is $14.60 and its two-hundred day moving average price is $15.84.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, equities analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.